Glaukos Corp Stock Today
GKOS Stock | USD 100.93 0.17 0.17% |
Performance7 of 100
| Odds Of DistressLess than 13
|
Glaukos Corp is selling for under 100.93 as of the 25th of April 2024; that is -0.17% down since the beginning of the trading day. The stock's lowest day price was 100.75. Glaukos Corp has less than a 13 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Glaukos Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of June 2015 | Category Healthcare | Classification Health Care |
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. The company has 50.19 M outstanding shares of which 3.49 M shares are currently shorted by private and institutional investors with about 6.98 trading days to cover. More on Glaukos Corp
Moving against Glaukos Stock
0.74 | BJDX | Bluejay Diagnostics Financial Report 8th of May 2024 | PairCorr |
0.74 | EFTR | Effector Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.71 | NRC | National Research Corp | PairCorr |
0.64 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
0.55 | TIVC | Tivic Health Systems | PairCorr |
0.51 | PRVA | Privia Health Group Financial Report 2nd of May 2024 | PairCorr |
0.5 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
Glaukos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Glaukos Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Glaukos Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman | Thomas Burns | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Glaukos Corp report their recommendations after researching Glaukos Corp's financial statements, talking to executives and customers, or listening in on Glaukos Corp's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Glaukos Corp. The Glaukos consensus assessment is calculated by taking the average forecast from all of the analysts covering Glaukos Corp. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the analysis of Glaukos Corp's profitability, liquidity, and operating efficiency, Glaukos Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Glaukos Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glaukos Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Glaukos Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Glaukos Corp's financial leverage. It provides some insight into what part of Glaukos Corp's total assets is financed by creditors.
|
Glaukos Corp (GKOS) is traded on New York Stock Exchange in USA. It is located in One Glaukos Way, Aliso Viejo, CA, United States, 92656 and employs 907 people. Glaukos Corp is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Glaukos Corp's market, we take the total number of its shares issued and multiply it by Glaukos Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Glaukos Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 50.19 M outstanding shares of which 3.49 M shares are currently shorted by private and institutional investors with about 6.98 trading days to cover.
Glaukos Corp currently holds about 391.19 M in cash with (57.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22.
Check Glaukos Corp Probability Of Bankruptcy
Ownership AllocationGlaukos Corp secures a total of 50.19 Million outstanding shares. The majority of Glaukos Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Glaukos Corp to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Glaukos Corp. Please pay attention to any change in the institutional holdings of Glaukos Corp as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Glaukos Ownership Details
Glaukos Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Glaukos Corp jumping above the current price in 90 days from now is about 1.98%. The Glaukos Corp probability density function shows the probability of Glaukos Corp stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.7409. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Glaukos Corp will likely underperform. Additionally, glaukos Corp has an alpha of 0.0156, implying that it can generate a 0.0156 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Glaukos Corp to move above the current price in 90 days from now is about 1.98 (This Glaukos Corp probability density function shows the probability of Glaukos Stock to fall within a particular range of prices over 90 days) .
Glaukos Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Glaukos Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Glaukos Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Glaukos Corp's value.Instituion | Recorded On | Shares | |
Millennium Management Llc | 2023-12-31 | 1 M | |
Geode Capital Management, Llc | 2023-12-31 | 1 M | |
Dimensional Fund Advisors, Inc. | 2023-12-31 | 923.5 K | |
Primecap Management Company | 2023-12-31 | 790 K | |
Braidwell Lp | 2023-09-30 | 695.8 K | |
Morgan Stanley - Brokerage Accounts | 2023-12-31 | 662.3 K | |
Driehaus Capital Management Llc | 2023-12-31 | 588.9 K | |
Capital World Investors | 2023-12-31 | 550.3 K | |
Riverbridge Partners Llc | 2023-12-31 | 548.1 K | |
Blackrock Inc | 2023-12-31 | 7.9 M | |
Fmr Inc | 2023-12-31 | 5.8 M |
Glaukos Corp Historical Income Statement
Glaukos Corp Income Statement is one of the three primary financial statements used for reporting Glaukos's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Glaukos Corp revenue and expense. Glaukos Corp Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Glaukos Corp's Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 14.3 M in 2024, whereas Total Revenue is likely to drop slightly above 194.7 M in 2024. View More FundamentalsGlaukos Stock Against Markets
Picking the right benchmark for Glaukos Corp stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Glaukos Corp stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Glaukos Corp is critical whether you are bullish or bearish towards Glaukos Corp at a given time. Please also check how Glaukos Corp's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Glaukos Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Glaukos Corp Corporate Directors
Glaukos Corp corporate directors refer to members of a Glaukos Corp board of directors. The board of directors generally takes responsibility for the Glaukos Corp's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Glaukos Corp's board members must vote for the resolution. The Glaukos Corp board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Gilbert Kliman | Independent Director | Profile | |
Jonathan Silverstein | Independent Director | Profile | |
Mark Foley | Lead Independent Director | Profile | |
Aimee Weisner | Independent Director | Profile |
How to buy Glaukos Stock?
Before investing in Glaukos Corp, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Glaukos Corp. To buy Glaukos Corp stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Glaukos Corp. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Glaukos Corp stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Glaukos Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Glaukos Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Glaukos Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Glaukos Stock please use our How to Invest in Glaukos Corp guide.
Already Invested in Glaukos Corp?
The danger of trading Glaukos Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Glaukos Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Glaukos Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Glaukos Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Glaukos Corp is a strong investment it is important to analyze Glaukos Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Glaukos Corp's future performance. For an informed investment choice regarding Glaukos Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Glaukos Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Glaukos Stock please use our How to Invest in Glaukos Corp guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Glaukos Stock analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Glaukos Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Glaukos Corp. If investors know Glaukos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Glaukos Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 18.963 | Earnings Share (2.78) | Revenue Per Share 6.498 | Quarterly Revenue Growth 0.156 | Return On Assets (0.08) |
The market value of Glaukos Corp is measured differently than its book value, which is the value of Glaukos that is recorded on the company's balance sheet. Investors also form their own opinion of Glaukos Corp's value that differs from its market value or its book value, called intrinsic value, which is Glaukos Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaukos Corp's market value can be influenced by many factors that don't directly affect Glaukos Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Glaukos Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaukos Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.